Immunocore Holdings plc (IMCR) News
Follow Immunocore Holdings plc (IMCR) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 9 public stories across 6 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Immunocore Reports Third-Quarter Financial Results and Business Update
EQUITY | Nov 06, 2026, 03:26 PM UTC
M
Immunocore Q3 Loss Misses Estimates on Higher R&D Spending
EQUITY | Nov 06, 2026, 02:11 PM UTC
M
Immunocore Reports Q3 Results, KIMMTRAK Revenue Reaches $102.2 Million
KIMMTRAK net revenues were $102.2 million in Q3 2026 and $324.8 million in the first nine months, up 10% year over year. Immunocore also said its Phase 3 TEBE-AM trial completed target enrollment of 540.
EQUITY | Nov 06, 2026, 02:03 PM UTC
L
Immunocore doses first patient in Phase 1 autoimmune trial
The first patient has been dosed in the Phase 1 trial of IMC-S118AI, Immunocore’s tissue-specific autoimmune candidate for type 1 diabetes.
EQUITY | Oct 15, 2026, 11:00 AM UTC
H
Immunocore Hldgs Q2 2026 Earnings Call Transcript
Immunocore Hldgs (NASDAQ: IMCR ) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. APIs provide real-time access to earnings ca
LIVE | Oct 05, 2026, 01:05 PM UTC
L
Immunocore to present at upcoming investor conferences
Immunocore Holdings plc says it will present at upcoming investor conferences, according to a TradingView News report.
EQUITY | Sep 01, 2026, 11:07 AM UTC
L
IMCR - Immunocore to present at upcoming investor conferences
IMCR - Immunocore to present at upcoming investor conferences
EQUITY | Sep 01, 2026, 11:00 AM UTC
L
IMCR - Immunocore reports second quarter financial results and provides a business update
IMCR - Immunocore reports second quarter financial results and provides a business update
EARNINGS | Aug 06, 2026, 11:00 AM UTC
L
IMCR - Immunocore to report second quarter 2026 financial results and host call on August 6, 2026
IMCR - Immunocore to report second quarter 2026 financial results and host call on August 6, 2026
EARNINGS | Jul 30, 2026, 11:00 AM UTC